Medicines – we’re told by the pharmaceuticals industry – are expensive by necessity owing to the high costs of research and development. Yet, as with the vaccines for Covid, much research is publicly-funded, and much comes out of universities. And, as Nick Dearden argues, only 3% of new drugs even represent actual breakthroughs. Instead most are “evergreened” drugs that Big Pharma tweaks in order to prolong its intellectual property rights. He discusses why the business of pharmaceuticals companies is not public health, but private profit. (Encore presentation.)

Resources:

Nick Dearden, Pharmanomics: How Big Pharma Destroys Global Health Verso, 2023

The post The Price of Big Pharma appeared first on KPFA.